AlphaFold predicted structure
GHR · P10912

Mean pLDDT
58.7/ 100
Low
638 residues
Confidence breakdown
- Very high(≥ 90)26%
- Confident(70–90)7%
- Low(50–70)16%
- Very low(< 50)51%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
growth hormone receptor
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
DDG2P
BIALLELIC, autosomal or pseudoautosomalFetal anomalies
BIALLELIC, autosomal or pseudoautosomalIUGR and IGF abnormalities
BIALLELIC, autosomal or pseudoautosomalMonogenic short stature
BIALLELIC, autosomal or pseudoautosomalPituitary hormone deficiency
BIALLELIC, autosomal or pseudoautosomalSkeletal dysplasia
BOTH monoallelic and biallelic, autosomal or pseudoautosomalFamilial hypercholesterolaemia
Intellectual disability
BIALLELIC, autosomal or pseudoautosomal+1 more panels — install the extension to see the full list inline on any page.
Laron syndrome
short stature due to partial GHR deficiency
Turner syndrome
acromegaly
pituitary dwarfism
Growth delay
Prader-Willi syndrome
chronic kidney disease
gonadal dysgenesis
growth hormone insensitivity syndrome
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Growth hormone receptor
Receptor for pituitary gland growth hormone (GH1) involved in regulating postnatal body growth (PubMed:1549776, PubMed:2825030, PubMed:8943276). On ligand binding, couples to the JAK2/STAT5 pathway (PubMed:1549776, PubMed:15690087, PubMed:2825030, PubMed:8943276)
GHR · P10912

Mean pLDDT
58.7/ 100
Low
638 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0